RSS

ARCHITECT

Abbott (NYSE: ABT) today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for develop more

May 9, 2013 12:00 AM News

Built with Metro Publisher™